EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Health care regulatory insights and strategic considerations
Actions for the health care industry to enable compliance and inform strategic decision-making.
Our health care regulatory team helps payers, providers, life sciences companies and other health care enablers sharpen their focus on the regulatory landscape for health care.
These regulatory briefs provide high-level takeaways and strategic analysis to help leaders digest the latest developments.
Post-Election Health Policy Outlook
The new administration will play a key role in shaping the future of health policy. Explore the implications of the electoral outcomes on health care.
With movement on health care policy accelerating and still top of mind for policymakers and the American public, having the right regulatory outlook is crucial for health care organizations. Our regulatory briefs help C-suite executives distill complex health care policy and regulatory matters, pinpointing key takeaways and action items to enable compliance and inform strategic decision-making.
Our seasoned team’s regulatory updates include topics involving both public and private health care with an eye toward providing timely, high-level health care policy analysis. As new policy developments emerge, watch this space for our latest insights, including strategic considerations that enable health care and life sciences leaders to act quickly and decisively.
How EY can help
-
Our Smart Health solutions can help your business become a smart health organization. Learn more.
Read more -
Washington Council Ernst & Young (WCEY) is a tax, legislative and regulatory group within Ernst & Young LLP that combines the power of a leading professional services organization with the on-the-ground knowledge, personal relationships and attention to detail of a boutique Washington-insider firm.
Read more -
Americas and US Tax Policy at Ernst & Young LLP is a one-stop resource for insights on national and state tax reform, tax policy, regulatory changes and legislation.
Read more
Our latest thinking on health care
Election aftermath: implications for life sciences companies
Join our webcast to explore the 2024 election’s impact on life sciences with insights on drug prices, supply chain and more. Register now!
Progress through policy: the digital health imperative
Explore how smart digital healthcare policy improves health equity, telehealth, EHR usage, nursing shortages, value based care, and patient centered care.
US Health Sector Update October 2023
In this webcast, we’ll present updates related to health policy, legislative payments, the Federal Emergency Management Agency (FEMA) regulatory environment and lessons learned for health care supply chain of the future.
Helping state Medicaid agencies make smart compliance decisions while securing maximum federal support.
MDRP proposed rule could impact 340B covered entities
340B covered entities should be aware of four changes proposed by the Centers for Medicare and Medicaid Services. Read to learn more.
Beyond HRSA: 340B risks related to Medicare and Medicaid
Are 340B entities giving enough attention to non-HRSA compliance obligations? Learn more.
Why recent regulatory changes require a deeper focus on health equity
Executives may need a new approach to enterprise-wide health equity improvement. Learn more.
How the end of the COVID-19 Public Health Emergency will impact payers
Discover payer strategies to navigate the end of the COVID-19 Public Health Emergency.